Literature DB >> 25543097

Emergence and spread of tetracycline resistant Vibrio cholerae O1 El Tor variant during 2010 cholera epidemic in the tribal areas of Odisha, India.

Santanu Kumar Kar1, Bibhuti Bhusan Pal2, Hemanta Kumar Khuntia1, K Gopinath Achary1, Chinmaye Priyadarshini Khuntia1.   

Abstract

OBJECTIVES: The epidemics of cholera were reported in the Kashipur, K.singhpur, B cuttack blocks of Rayagada district and Mohana block of Gajapati district of Odisha during 2010. The present study was carried out to isolate the bacterial pathogen, its drug sensitivity pattern and to describe the spread of the disease in those areas.
METHODS: A total of 68 rectal swabs collected from patients with severe diarrhea, admitted to different health centers and diarrhea affected villages were bacteriologically analyzed. Similarly 22 water samples collected from different villages from nala, chua, etc were tested for the presence of V cholerae.
RESULTS: Out of 68 rectal swabs tested 35 (51.5%) were V cholerae O1 Ogawa and 14(20.6%) were E coli; which might be commensals. All water samples were negative for V cholerae. The V cholerae strains were sensitive to gentamicin, norfloxacin, ciprofloxacin, azithromycin and ofloxacin; but were resistant to ampicillin, tetracycline, nalidixic acid, furazolidone, streptomycin, erythromycin, co-trimoxazole, neomycin and chloramphenicol. All V cholerae strains were 100% resistant to tetracycline and they were El Tor variants harboring ctxB gene of classical strain.
CONCLUSIONS: The present study indicated the emergence and spread of tetracycline resistant V cholerae O1 El Tor variant in the tribal areas which needs close monitoring.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  El Tor variant; Tetracycline resistance; V cholerae; spread

Mesh:

Substances:

Year:  2014        PMID: 25543097     DOI: 10.1016/j.ijid.2014.12.025

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  7 in total

Review 1.  Cholera: an overview with reference to the Yemen epidemic.

Authors:  Ali A Rabaan
Journal:  Front Med       Date:  2018-06-22       Impact factor: 4.592

2.  Phenotypic and antibiogram pattern of V. cholerae isolates from a tertiary care hospital in Mumbai during 2004-2013: a retrospective cross-sectional study.

Authors:  V Torane; S Kuyare; G Nataraj; P Mehta; S Dutta; B Sarkar
Journal:  BMJ Open       Date:  2016-11-25       Impact factor: 2.692

3.  Prevalence of Vibrio cholerae O1 serogroup in Assam, India: A hospital-based study.

Authors:  Ajanta Sharma; Bornali Sarmah Dutta; Elmy Samsun Rasul; Dipa Barkataki; Anjanamoyee Saikia; Naba Kumar Hazarika
Journal:  Indian J Med Res       Date:  2017-09       Impact factor: 2.375

Review 4.  Drug Resistance and the Prevention Strategies in Food Borne Bacteria: An Update Review.

Authors:  Fataneh Hashempour-Baltork; Hedayat Hosseini; Saeedeh Shojaee-Aliabadi; Mohammadali Torbati; Adel Mirza Alizadeh; Matin Alizadeh
Journal:  Adv Pharm Bull       Date:  2019-08-01

5.  Phylogenetic and antimicrobial drug resistance analysis of Vibrio cholerae O1 isolates from Ghana.

Authors:  Japheth A Opintan; Robert C Will; George K Kuma; Mary Osei; Amos Akumwena; Gifty Boateng; Godfred Owusu-Okyere; Lorreta Antwi; David Opare; Agila Kumari Pragasam; Karthick Vasudevan; Sunil Kumar Srivastava; Veeraraghavan Balaji; Mercy J Newman; Gordon Dougan; Ankur Mutreja
Journal:  Microb Genom       Date:  2021-10

6.  Decades of cholera in Odisha, India (1993-2015): lessons learned and the ways forward.

Authors:  Hemant Kumar Khuntia; Thandavarayan Ramamurthy; Madhusmita Bal; Sanghamitra Pati; Manoranjan Ranjit
Journal:  Epidemiol Infect       Date:  2021-06-07       Impact factor: 2.451

7.  Global status of tetracycline resistance among clinical isolates of Vibrio cholerae: a systematic review and meta-analysis.

Authors:  Mohammad Hossein Ahmadi
Journal:  Antimicrob Resist Infect Control       Date:  2021-08-06       Impact factor: 4.887

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.